Literature DB >> 7479068

Members of a family of proteins (the RD family) detected by a U1 70K monoclonal antibody are present in spliceosomal complexes.

D Staknis1, R Reed.   

Abstract

We have characterized a monoclonal antibody (mAb) to the U1 snRNP component U1 70K. We find that this antibody recognizes several proteins, in addition to U1 70K, in purified spliceosomal complexes and in total HeLa cell nuclear extract preparations. The novel mAb U1 70K antigens can also be specifically immunoprecipitated by the antibody. Similarly to U1 70K, many of the mAb U1 70K antigens can be phosphorylated by a co-purifying kinase activity. The epitope recognized by mAb U1 70K was previously shown to be a repeating arginine/aspartate (RD) dipeptide. Thus we have designated the novel mAb U1 70K antigens the RD family. Comparison of mAb U1 70K with a recently characterized antibody, mAb 16H3, whose epitope is a repeating R/D or R/E motif, showed that a large subset of the antigens are common. In contrast, most of the mAb U1 70K antigens are distinct from the proteins detected by mAb 104, an antibody to the SR family of splicing factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479068      PMCID: PMC307346          DOI: 10.1093/nar/23.20.4081

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition.

Authors:  M Bach; G Winkelmann; R Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus.

Authors:  X D Fu; T Maniatis
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

3.  Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells.

Authors:  A R Krainer; G C Conway; D Kozak
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

4.  Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor.

Authors:  P D Zamore; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  A previously undetected MHC gene with an unusual periodic structure.

Authors:  M Lévi-Strauss; M C Carroll; M Steinmetz; T Meo
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

6.  The human U1-70K snRNP protein: cDNA cloning, chromosomal localization, expression, alternative splicing and RNA-binding.

Authors:  R A Spritz; K Strunk; C S Surowy; S O Hoch; D E Barton; U Francke
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

7.  The human RD protein is closely related to nuclear RNA-binding proteins and has been highly conserved.

Authors:  C S Surowy; G Hoganson; J Gosink; K Strunk; R A Spritz
Journal:  Gene       Date:  1990-06-15       Impact factor: 3.688

8.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

9.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro.

Authors:  H Ge; J L Manley
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

10.  A conserved epitope on a subset of SR proteins defines a larger family of Pre-mRNA splicing factors.

Authors:  K M Neugebauer; J A Stolk; M B Roth
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

View more
  11 in total

1.  Association of polyadenylation cleavage factor I with U1 snRNP.

Authors:  Sita Awasthi; James C Alwine
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

2.  Identification of a human protein that recognizes the 3' splice site during the second step of pre-mRNA splicing.

Authors:  S Wu; M R Green
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals.

Authors:  M D Chiara; L Palandjian; R Feld Kramer; R Reed
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

4.  Luc7p, a novel yeast U1 snRNP protein with a role in 5' splice site recognition.

Authors:  P Fortes; D Bilbao-Cortés; M Fornerod; G Rigaut; W Raymond; B Séraphin; I W Mattaj
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

5.  The human La (SS-B) autoantigen interacts with DDX15/hPrp43, a putative DEAH-box RNA helicase.

Authors:  Michael A Fouraux; Marloes J M Kolkman; Annemarie Van der Heijden; Arjan S De Jong; Walther J Van Venrooij; Ger J M Pruijn
Journal:  RNA       Date:  2002-11       Impact factor: 4.942

6.  SMU-2 and SMU-1, Caenorhabditis elegans homologs of mammalian spliceosome-associated proteins RED and fSAP57, work together to affect splice site choice.

Authors:  Angela K Spartz; Robert K Herman; Jocelyn E Shaw
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.

Authors:  S H Xiao; J L Manley
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

8.  The mammalian homologue of Prp16p is overexpressed in a cell line tolerant to Leflunomide, a new immunoregulatory drug effective against rheumatoid arthritis.

Authors:  D Ortlepp; B Laggerbauer; S Müllner; T Achsel; B Kirschbaum; R Lührmann
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

9.  Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death.

Authors:  P J Utz; M Hottelet; W J van Venrooij; P Anderson
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  Nuclear export and retention signals in the RS domain of SR proteins.

Authors:  Demian Cazalla; Jun Zhu; Lisa Manche; Elisabeth Huber; Adrian R Krainer; Javier F Cáceres
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.